Ownership history in CM Management, LLC · 19 quarters on record
This page tracks every 13F SEC filing in which CM Management, LLC reported a position in ATEA PHARMACEUTICALS INC (AVIR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 355,000 | -145,000 | -29.0% | 1.07% | $1.3M | $3.57 |
| 2025 Q3 | UNCHANGED | 500,000 | — | 0% | 1.21% | $1.4M | $2.90 |
| 2025 Q2 | UNCHANGED | 500,000 | — | 0% | 1.64% | $1.8M | $3.60 |
| 2025 Q1 | ADDED | 500,000 | +200,000 | +66.7% | 1.50% | $1.5M | $2.99 |
| 2024 Q4 | ADDED | 300,000 | +30,000 | +11.1% | 0.90% | $1.0M | $3.35 |
| 2024 Q3 | UNCHANGED | 270,000 | — | 0% | 0.72% | $904K | $3.35 |
| 2024 Q2 | UNCHANGED | 270,000 | — | 0% | 0.82% | $894K | $3.31 |
| 2024 Q1 | UNCHANGED | 270,000 | — | 0% | 0.92% | $1.1M | $4.04 |
| 2023 Q4 | REDUCED | 270,000 | -5,000 | -1.8% | 0.66% | $824K | $3.05 |
| 2023 Q3 | ADDED | 275,000 | +25,000 | +10.0% | 0.88% | $825K | $3.00 |
As of 2025 Q4 — sorted by position size